| 23:31 08/09/2010 | OMG |
| OMG, some of you guys are still here after all these years, like 10. This company had great potential but unfortunately it had some inept people in charge. I am not saying "I told you so", but some people should be banned from investing their own money for failing to follow basic principles such as stop losses and not putting eggs in one basket. Hope it turns out OK for you and you recoup. Sincerely wishing you "bon chance". By Mr Schruh den Vester |
|
| 12:59 24/08/2010 | Re: Once was so beautiful |
| If the shares were £1.83 each then the market cap would be that value x the number of shares in issue = "over £4 Billion" So you are indicating that the number of shares remaining after the 10-for-1 is actually the same as it was before? Just the nominal value is reduced by a factor of 10 (from 10p to 1p I think?) The extreme share spike you refer to lasted for a matter of days and was totally crazy! If anyone did buy at the top of it they should have sold after the initial collapse. Incidentally over 60% took part in that "dilutive fund raising" so their holdings were not actually diluted in percentage terms. By Patrick K Murphy |
|
| 12:05 24/08/2010 | any upside? |
| Does this share have any chance of recovery? It's a sick dog and I hate licking my wounds. By Goathandle |
|
| 11:49 24/08/2010 | Re: Once was so beautiful |
| Yet more incorrect information. >There was also share split and cancellation of "deferred" shares at the >time. Effectively that would also reduce the £1.83 by changing the >number of equivalent shares. No. The 10-for-1 split (resulting in 1 new interim share and 9 deferred shares) followed by cancellation of deferred shares was simply a technical mechanism implemented to enable the 1-for-100 consolidation to take place. In itself it had no effect on the shares outstanding calculation. The relevant number is 100. A £1.83 share price in old money is the equivalent of £183 now. >Work out what the market cap would have been at that price What's the market cap got to do with it? I get the feeling you don't understand the difference between a dilutive fund raising and a stock split/consolidation. By Biomole99 |
|
| 10:59 24/08/2010 | Re: TRAPPED - Too cheap to sell |
| My £1133.59 was worth £390.00 yesterday. Do you really only have 23 shares? £65.00 a share? Rounding up to 1000 at 29 a few weeks back could have helped. (outlay £1783 now £390.00) Not much better I guess. Incidentally, Abbot was a partner, carrying development costs, not strictly a customer. By Patrick K Murphy |
|
| 10:36 24/08/2010 | Re: Once was so beautiful |
| Er... £1.83 per share in old money becomes £183 per share after the 2008 100-for-1 stock consolidation. Where's the error? Work out what the market cap would have been at that price - Do you think £4Billion realistic? I certainly don't. There was also share split and cancellation of "deferred" shares at the time. Effectively that would also reduce the £1.83 by changing the number of equivalent shares. By Patrick K Murphy |
|
| 10:19 24/08/2010 | Re: Once was so beautiful |
| Er... £1.83 per share in old money becomes £183 per share after the 2008 100-for-1 stock consolidation. Where's the error? Just as an aside, in order for SKP to reach this level its stock price would need to increase by a mere 45800%. Fancy your chances? By Biomole99 |
|
| 12:02 21/08/2010 | TRAPPED - Too cheap to sell |
| Looks like the last chance to make a profit from Flutiform has now gone. They haven't "regained the rights" - they just lost the only customer. Unfortunately my investment (HA!) of £1500 is now worth £8.80 so I cant even afford the dealing charges to dump it - It just sits there and annoys me. Bring back Ian Gowrie Smith. Robbin By RobbinK |
|
| 17:44 20/08/2010 | Re: Once was so beautiful |
| IMHO there is a big error in that calculation. By Patrick K Murphy |
|
| 13:31 20/08/2010 | Re: Once was so beautiful |
| £190 a share! By Misty Creamybib |
|
| 13:30 20/08/2010 | Once was so beautiful |
| Skyepharma will always have a place in heart and I have a framed share certificate at home, the very home Skyepharma allowed me to put down a hefty deposit on. It was the late 90's I was in my mid to late twenties and times were good. A lot of my friends were piling their bonuses into technology stocks, Atlantic Telecom, Skillsgroup, Marconi and QXL ricardo. I was unsure of the hefty valuations placed on some of these stocks and whilst I had a dabble with Atlantic Telecom where I got out 30% down I liked the idea of investing biotech. (figures in old shares) I started buying investment chronicle where Skyepharma was tipped at about 70p and bought in about 68p. The share rose to about 82p before drifting back down. I averaged back in at 48p and 38p holding a total of 6600 shares. The share moved sideways for a year until one day it reach 85p- Suddenly there was an announcement about the potential of the human genome project and the cloning of Dolly the sheep. In two weeks the share price surged to £1.83. The following day the share trade down 2p and in the afternoon I took the decision to sell 6000 shares leaving the other 600 as a long term investment, the £11,000 paid for a 10% deposit on my £82,000 terrace and some furnishing to boot. as for the shares I have left, they are worth less than the dealing cost to sell them, hence the framed certificate. Any opinions on when we are likely to see £19 a share again? * I had friend who was so impressed with this he bought my other tip - Scotia Holdings! By Misty Creamybib |
|
| 10:57 17/08/2010 | Re: New CEO and results |
| That is NOT about "strategy"! It concerns a situation at a plant making a drug. Not dissimilar to the problem SKP had with one making (Paxil if I remember correctly) one of Skyes products. Negative spin AGAIN! By Patrick K Murphy |
|
| 8:54 17/08/2010 | Re: New CEO and results |
| OK, hands up who had heard of Acino Holding before today. At least Herr Muller is used to cockups, which should stand him in good stead at his new employers. Here's a helpful article about Acino's manufacturing strategy: http://www.reuters.com/article/idUSLDE63C0X420100413 By Biomole99 |
|
| 8:36 17/08/2010 | New CEO and results |
| See RNS. A new CEO with considerable experience and results due on the 19th. August. Soon see if the rally in price was justified or not. CEO takes up post on 23rd. Perhaps he will take up some stock then? By Patrick K Murphy |
|
| 9:01 06/08/2010 | Re: 4p Spread |
| That spread gave the "5% drop" today on the "last trade" By Patrick K Murphy |
|